Drug interactions between Cardizem LA and potassium chloride
| Results for the following 2 drugs: |
|---|
| Cardizem LA (diltiazem) |
| potassium chloride |
Interactions between your drugs
There were no interactions found in our database between Cardizem LA and potassium chloride - however, this does not necessarily mean no interactions exist. Always consult with your doctor or pharmacist.
Cardizem LA
A total of 967 drugs are known to interact with Cardizem LA.
- Cardizem LA is in the following drug classes: calcium channel blocking agents, group IV antiarrhythmics.
- Cardizem LA is used to treat the following conditions:
potassium chloride
A total of 426 drugs are known to interact with potassium chloride.
- Potassium chloride is a member of the drug class minerals and electrolytes.
- Potassium chloride is used to treat the following conditions:
Drug and food interactions
dilTIAZem food
Applies to: Cardizem LA (diltiazem)
Alcohol can lower your blood pressure and add to the effects of dilTIAZem. You may experience dizziness, lightheadedness, fainting, or a rapid heartbeat if you drink alcohol with dilTIAZem, especially when you first start taking the medication or just after a dose increase. Grapefruit juice may also increase the effects of dilTIAZem in some people by increasing its levels in the blood. You may want to limit alcohol intake and avoid excessive consumption of grapefruit and grapefruit juice during treatment with dilTIAZem. However, if you have been regularly consuming grapefruit or grapefruit juice with dilTIAZem, do not alter the amounts of these products in your diet without first talking to your doctor or other healthcare professional. Contact your doctor if your condition changes or you experience increased side effects of dilTIAZem such as headache, irregular heartbeat, swelling, unexplained weight gain, or chest pain. Orange juice is not expected to interact.
Therapeutic duplication warnings
No warnings were found for your selected drugs.
Therapeutic duplication warnings are only returned when drugs within the same group exceed the recommended therapeutic duplication maximum.
See Also
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No information available. |
Do not stop taking any medications without consulting your healthcare provider.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
